期刊文献+

局部枸橼酸抗凝和肝素抗凝在危重病人血液滤过治疗中的比较 被引量:6

Comparison of the clinical effect between regional citrate anticoagulation and heparin anticoagulation in severe patients treated with blood filtration
下载PDF
导出
摘要 目的:分析局部枸橼酸抗凝(RCA)和普通肝素抗凝在危急重症病人行持续性静脉-静脉血液滤过治疗(CVVH)中的临床效果。方法:回顾性分析45例行CVVH治疗的危急重症病人临床资料,根据抗凝方法不同分为RCA-CVVH组(RCA组,25例)和普通肝素抗凝CVVH组(肝素组,20例),比较2组病人治疗前后凝血功能、内环境、肾功能、出血并发症发生情况以及滤器寿命方面的差异。结果:治疗后,RCA组病人活化部分凝血活酶时间(APTT)、凝血酶原时间(PT)时间较治疗前无明显变化(P>0.05),尿素氮(BUN)、血肌酐(Cr)水平明显降低(P<0.01);肝素组病人APTT与PT时间较治疗前延长(P<0.01),BUN和Cr水平较治疗前均明显下降(P<0.01)。RCA组Na^+、Ca^(2+)水平较治疗前下降(P<0.05),HCO_3^-和p H值无明显变化(P>0.05);而肝素组治疗前后Na^+、Ca^(2+)、HCO_3^-和p H值均无明显变化(P>0.05)。RCA组继发出血1例(4%),低于肝素组的3例(15%)(P<0.05);RCA组平均滤器使用寿命为(35.26±7.60)h,长于肝素组的(20.75±5.3)h(P<0.01)。结论:RCA具有与肝素抗凝病人相似的滤过效果,而且对凝血功能影响较小,不增加危急重症病人出血风险,还能延长滤器的使用寿命,具有更高的安全性和实用性。 Objective:To compare the clinical effects between regional citrate anticoagulation(RCA) and heparin anticoagulation in severe patients treated with continuous venous-venous hemofiltration( CVVH) . Methods:The clinical data of 45 severe patients treated with CVVH were retrospectively analyzed. The patients were divided into the RCA-CVVH group( RCA group,25 cases) and heparin anticoagulation CVVH group ( heparin group, 20 cases ) according to the anticoagulation method. The differences of the coagulant function,internal environment,renal function,bleeding complication and filter longevity before and after treatment between two groups were compared. Results:The differences of the activated partial thromboplastin time( APTT) and prothrombin time( PT) in RCA-CVVH group between before and after treatment were not statistically significant(P〉0. 05),and the levels of the Cr and BUN in RCA-CVVH group significantly decreased after treatment(P 〈0. 01). Compared before treatment,the APTT and PT in heparin-CVVH group prolonged after treatment(P〈0. 01),and the levels of the Cr and BUN in heparin-CVVH group significantly decreased after treatment (P〈0. 01). Compared before treatment,the levels of Na+ and Ca2 + in RCA group decreased after treatment(P〈0. 01),the changes of the level of HCO3-and pH value in RCA group were not obvious after treatment(P〉0. 05). Compared before treatment,the changes of the levels of Na+,Ca2 + and HCO3-,and pH value in heparin group were not obvious after treatment(P〉0. 05). The secondary hemorrhage in RCA group(1 cases,4%) was lower than that in heparin group(3 cases,15%)(P〈0. 05). The filter longevity in RCA group[(35.26&#177;7.60)h]waslongerthanthatinheparingroup[(20.75&#177;5.3)h](P〈0.01).Conclusions:Thefiltrationeffectof RCA-CVVH is similar to heparin,which is less effect on the coagulation function,does not increase the bleeding risk in severe patients, can prolong the filter longevity,and has better security and practicability.
作者 刘如喜 刘成产 褚明永 周杰 李敏 祝经韬 LIU Ru-xi LIU Cheng-chan ZHU Ming-yong ZHOU Jie LI Ming ZHU Jing-tao(ICU,Anhui North Coal Power Group Hospital ,Suzhou Anhui 234000, Chin)
出处 《蚌埠医学院学报》 CAS 2017年第7期916-918,共3页 Journal of Bengbu Medical College
关键词 血液过滤 抗凝治疗 枸橼酸 普通肝素 blood filtration anticoagulation therapy citrate heparin
  • 相关文献

参考文献6

二级参考文献60

  • 1桂保松,吕星,高卫华,王亮琪,郭蕊军,姚钢炼.新型枸橼酸盐浓缩抗凝血液透析液的实验研究[J].中国血液净化,2002,1(3):36-41. 被引量:13
  • 2陈凤锟,李冀军,陈璞,赵长征,龚红英,姚冬芳.高危出血风险患者无肝素透析后肝素盐水封管对凝血指标的影响[J].中国血液净化,2012,11(5):245-248. 被引量:17
  • 3桂保松,赵光本,昝瑛,马小琴,赵莉,卫小红.新型枸橼酸盐抗凝血液透析液溶质清除效果研究[J].中国实用内科杂志,2005,25(4):328-330. 被引量:4
  • 4贾利宁,桂保松.枸橼酸钠抗凝在血液净化中的应用进展[J].国际移植与血液净化杂志,2006,4(4):7-10. 被引量:16
  • 5Monehi M, Berghmans D, Ledoux D, et al. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration : a prospective randomized study [J]. Intensive Care Med, 2004,30 : 260 - 265.
  • 6Kutsogiannis DJ, Gibney NRT, Stollery D, et al. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients [ J ]. Kidney International,2005, 67:2361 - 2367.
  • 7Bagshaw SM, Laupland KB, Boiteau PJ,et al. Is regional citrate superior to systemic heparin antieoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system [ J ]. J Crit Care,2005,20 ( 2 ) : 155 - 161.
  • 8Oudemans SHW, Bouman RJ, Koopmans M, et al. Citrate anticoagulation for eontinous venovenous hemofiltration [ J ]. Crit Care Meal,2009,37 (2) :545 - 552.
  • 9Cassina T, Mauri R, Engeler Aet al. Continuous veno-venous hemofiltration with regional citrate antieoagulation : a four-year singlecenter experience. Int J Artif Organs. 2008,31 ( 11 ) :937 -943.
  • 10Apsner R, Buchmayer H, Lang T,et al. Simplified citrate anticoagulation for high-flux hemodialysis. Am J Kidney Dis, 2001,38 ( 5 ):979-987.

共引文献93

同被引文献72

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部